Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Stena Livia joins the Baltic Sea fleet

Stena Line/Stena Rederi A/S today announce the latest addition to their Baltic Sea fleet. The 186 metre long Visentini RoPax vessel Stena Livia will initially join sister vessel Stena Flavia on the Nynäshamn-Ventspils route from mid-April. Later this year the pair will replace the existing tonnage on the ferry route between Travemünde and Liepaja, adding 40 per cent freight capacity and shorten the crossing time substantially.During 2021 Stena Line is expanding their Baltic Sea operations with modern and large RoPax vessels being added to the two ferry routes from Latvia to Sweden and

P CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS ALPHA

Press release P Capital today announces that, at the close of business on 31 March 2021, the Net Asset Value of Proventus Capital Partners Alpha participation loan amounted to SEK 807,380 per debenture. Ordinary income of SEK 22,080 per debenture will be distributed to debenture holders on 16 April 2021. A partial repayment of the participation loan debentures amounting to SEK 55,000 per debenture will be made on 30 April 2021 Proventus Capital Partners Alpha’s assets are composed of 100 per cent privately issued corporate loans. During the quarter one private loan was fully

P CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS III

Press release P Capital today announces that, at the close of business on 31 March 2021, the Net Asset Value per participation loan debentures of Proventus Capital Partners III, was SEK 347,938 for series A and SEK 8,701,679 for series B. Ordinary income of SEK 6,949 per series A participation loan debenture and SEK 176,947 per series B participation loan debenture will be distributed on 16 April 2021. A partial repayment will be made on 30 April 2021 amounting to SEK 9,000 per series A debenture and SEK 225,000 per series B debenture. Proventus Capital Partners III’s assets are

P CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS IV

Press release P Capital today announces that, at the close of business on 31 March 2021, the Net Asset Value, per participation loan debentures of Proventus Capital Partners IV, is EUR 104.25 for series A1. Ordinary Income of EUR 2.28 per series A1 participation loan debentures will be distributed to debenture holders on 23 April 2021. No repayment of capital will be distributed to debenture holders for the quarter. Proventus Capital Partners IV’s assets are composed of 97.1 per cent privately issued corporate loans and 2.9 per cent publicly traded corporate bonds. P Capital is

P CAPITAL ANNOUNCES NAV OF PROVENTUS CAPITAL PARTNERS IV B

Press release P Capital today announces that, at the close of business on 31 March 2021, the Net Asset Value per participation loan debentures of Proventus Capital Partners IV B, is EUR 103.44 for series A1 and EUR 1,035.59 for series B. Ordinary Income of EUR 1.86 per series A1 participation loan debentures and EUR 19.78 per series B participation loan debenture will be distributed on 23 April 2021. No repayment of capital will be distributed to debenture holders for the quarter. Proventus Capital Partners IV B’s assets are composed of 97.1 per cent private high-yield loans and 2.

Invitation to conference call and webcast presentation of Dometic’s interim report for the first quarter 2021

Dometic Group AB (publ) will publish its interim report for the first quarter 2021 at around 08.00 CEST on Friday, April 23, 2021. On the same day at 10.00 CEST, Dometic will host a conference call and webcast to present the results. The presentation can be followed live via webcast and will also be available afterwards. The presentation will be held in English. The report and the presentation material will be available on Dometic’s website, www.dometic.com/ir Webcast link: https://onlinexperiences.com/Launch/QReg/ShowUUID=EB712CA3-72F4-41E1-806D-7697477BAE1F 

SciBase publishes the Annual report for 2020

SciBase hereby announces that the Annual report for 2020 is available at the Company’s website www.scibase.com.A pdf-version of the annual report is enclosed to this press-release.A printed version of the Annual report will only be distributed to shareholders who actively request a printed copy.For more information, please contact: Michael Colérus, CFO Tel: +46 70 341 34 72 E-mail: michael.colerus@scibase.com Certified Advisor Avanza Tel: +46 8 409 421 20 E-mail: ca@avanza.se The information was submitted for publication, through the agency of the contact person

Probi publishes Annual Report for 2020

Probi's Annual Report and Sustainability Report for 2020 are now available on the company website, www.probi.com under Investor Relations: https://www.probi.com/investor-relations/financial-reports/   This information is information that Probi AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 9.00 CET on 9 April 2021. For further information, please contact: Henrik Lundkvist, CFO, Phone +46 46 286 89 41, E-mail: henrik.lundkvist@probi.com   ABOUT PROBI Probi[®] is a global company focused exclusively on

Invitation to SSAB’s report for the first quarter of 2021

SSAB invites you to a presentation of the report for the first quarter of 2021 at 9.30am CEST on Monday, April 26, 2021. The briefing will take place by conference call that will also be webcast on SSAB’s website. The report will be published at approximately 7.30am CEST on the same date.The report for the first quarter of 2021 will be presented by SSAB’s President and CEO Martin Lindqvist, and CFO Håkan Folin. The briefing will be held in English. Time of briefing: Monday, April 26, 2021 at 9.30am CEST. Teleconference numbers:Sweden:                        +46 856 6426 51United

Invitation to Investor Meeting April 29, 2021

Welcome to MSAB's digital investment meeting on April 29 at 9:00 - 10:30, in connection with the financial reporting of the first quarter of 2021. During the presentation, you will get a more detailed description of MSAB as a company. The goal is to provide a wider and deeper understanding of the company, the business model, markets, and how MSAB sees the future of mobile forensics. Agenda: - Introduction of MSAB - Strategy & Opportunities - Innovations - Markets & Customers - Financial goals and investment management - Wrap up & discussion Register to the webinar

BioStock: BiBBInstruments submits third international patent application

On Thursday, BiBBInstruments announced that the company has filed another international patent application regarding EndoDrill Model X, an electric biopsy instrument for endoscopic use that will contribute to earlier cancer diagnoses. The company has so far applied for a total of three patents for EndoDrill Model X, and with this application the company intends to further strengthen the patent protection for the product.Read the full article at biostock.se: https://www.biostock.se/en/bibbinstruments-submits-third-international-patent-application/ This is a press release from BioStock -

Annual Report from Cyxone AB for the period 1 January 2020 to 31 December 2020

Cyxone AB’s Annual Report for the financial year 2020 is now available at the company’s website (www.cyxone.com).Please see attached Annual Report as pdf. Contact Tara Heitner, CEOTel: +46 70 781 88 08Email: tara.heitner@cyxone.comAdelgatan 21211 22 Malmö, Sweden About Cyxone Cyxone AB (publ) (Nasdaq First North Growth Market: CYXO) develops disease modifying therapies for diseases such as rheumatoid arthritis and multiple sclerosis as well as treatments for virally induced acute respiratory disorders. Rabeximod is a Phase 2 candidate drug being evaluated for the

Invitation to presentation of NOTE´s Interim Report on 19 April

The Interim Report for the first quarter 2021 will be published 19 April at 8:30 a.m. CET. The same day, at 10:00 a.m. CET, NOTE will arrange a teleconference for analysts, media and investors. The report will be presented by NOTE’s CEO and President Johannes Lind-Widestam. The presentation will be held in English. To join the meeting, paste this link in your browser. If you have a problem connecting, try another browser. https://teams.microsoft.com/l/meetup-join/19%3ameeting_ODY3MmIwNjQtNmExNC00MDEzLThjYzgtMjZiNzdmOTExMWI2%40thread.v2/0?context=%7b%22Tid%22%3a%22343c6c80-6b68-4f74-

Notice to attend the Annual General Meeting of SyntheticMR AB (publ)

The shareholders of SyntheticMR AB (publ) corporate id. No. 556723-8877 are hereby called to attend the Annual General Meeting (AGM) on Tuesday, May 11, 2021, at 18.00 at the company's premises, Storgatan 11, Linköping.  Participation Shareholders who wish to attend the AGM must: · be registered as a shareholder in share register maintained by Euroclear Sweden AB on Monday, May 3, 2021, and · notify its intention to attend the Annual General Meeting to SyntheticMR at the latest Wednesday, May 5, 2021 at 16.00 - By e-mail to info@syntheticmr.se (please state "

American Shipping Company ASA - American Tanker, Inc.: Successfully completed bond tap issue

Lysaker, 9 April 2021 American Tanker, Inc ("ATI"), an indirectly wholly owned subsidiary of American Shipping Company ASA (OSE:AMSC, OTCQX:ASCJF) has today carried out a tap issue of USD 20 million in the senior unsecured bond due 2 July 2025 with ISIN NO0010886328 and ticker ATI02. The tap issue was made at an issue price of 101% of nominal amount. Settlement of the tap issue is expected to take place on or about 16 April 2021. Following settlement, the outstanding amount under ATI02 will be USD 220 million. The bonds will trade on a separate ISIN for up to 40 days following the

Board of Directors of Momentum Group to investigate the possibility of splitting the Group into two separate listed companies

The Board of Directors of Momentum Group AB (publ) has decided to assign Group management the task of investigating the possibility of splitting the Group into two separate listed companies as well as the conditions for such a split. The aim would be to increase shareholder value in both the short and long term by increased focus. Further information on the results of the investigation will be presented by the Board during the financial year. The Momentum Group currently comprises two strong, operationally independent business areas with separate focus areas and dedicated management

Invitation to presentation of Hexagon's Interim Report on 29 April

Hexagon will release its Interim Report for the first quarter 2021 on Thursday 29 April at approximately 13:00 CET. A combined telephone conference and live webcast concerning the report will be presented by President and CEO Ola Rollén on the same day at 14:00 CET.Please call +46 (0) 8 566 426 51 (SWE), +44 (0) 333 300 0804 (UK), +1 631 913 1422 (US) (code: 52401531#) to participate or go to the website (hexagon.com) to access the webcast.The presentation material will also be available for viewing on the Company’s website on-demand.For further information, please contact:Maria

Notice to attend the annual general meeting of Recipharm AB (publ)

The shareholders of Recipharm AB (publ), Reg. No. 556498-8425 (the “Company”), are hereby invited to attend the annual general meeting to be held on Tuesday, 11 May 2021, only by postal voting. Due to the coronavirus and in an effort to reduce the spread, the Board of Directors has resolved that the Annual General Meeting will be held without the physical presence of shareholders, representatives and third parties, and that the shareholders will only be able to exercise their voting rights through postal voting in accordance with the instructions specified below. Information regarding

Hansa Biopharma: Notice to Annual General Meeting

Lund, Sweden April 9, 2021 Hansa Biopharma AB (publ), Reg. No. 556734-5359, with registered office in Lund, gives notice to Annual General Meeting on Wednesday May 12, 2021. In order to mitigate the spread of Covid-19, the Board of Directors has decided that the Annual General Meeting will be conducted by advance voting only, without physical presence of shareholders, proxies and third parties. Hansa Biopharma welcomes all shareholders to exercise their voting rights at this Annual General Meeting through advance voting on the basis of temporary statutory rules, according to the

Nel ASA: Enters into framework agreement with Wood

(Oslo, 9 April 2021) Nel ASA (Nel, OSE:NEL) has entered into a framework agreement with the global consulting and engineering company Wood (LSE: JOHN). The companies will collaborate to develop and execute large scale, complex green renewable hydrogen projects in select regions across the world. "We are very excited to be entering into this agreement with Wood, who has extensive experience from large, complex projects worldwide. As green hydrogen projects are growing in size and complexity, it is crucial for our success to have strong partners to strengthen our project management- and

Sweco acquires Finnish architecture company Linja Arkkitehdit

Sweco has signed an agreement to acquire Linja Arkkitehdit Oy, specialised in design of educational and business premises as well as residential buildings. With the acquisition Sweco becomes one of the largest architecture companies in Finland.Linja Arkkitehdit Oy has approximately 60 architects located in Oulu, Helsinki and Jyväskylä. The company offers architectural services in the design of educational establishments, residential premises and business premises. The revenue of Linja Arkkitehdit during 2020 was EUR 5.3 million. “This acquisition is fully in line with our history and

Read original
There are no items matching the current filter
There are no more items matching the current filter
Back to top